Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Baehring, Joachim M
PROSPECT, NCT04947319: Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma ( Study)	Recruiting	2	112	US	Tirabrutinib, ONO-4059	Ono Pharmaceutical Co. Ltd	Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma	03/27	03/27
NCT04656535: AB154 Combined with AB122 for Recurrent Glioblastoma	Recruiting	1	46	US	Zimberelimab, Domvanalimab, Placebo	Yale University, National Cancer Institute (NCI), Arcus Biosciences, Inc.	Glioblastoma	02/25	12/25